Study number 8535-660
1 Stay of 11 Nights & 1 Follow up
Dates
Oct 20 2024-Nov 05 2024
Location
Dallas, Texas
Age
18-55
Gender
Both Males and Females
Compensation
$5,671
Group
G2
Study Details
The purpose of this study is to evaluate the effects on the amount of study drug, midazolam, and repaglinide that reaches the blood stream and how long the body takes to get rid of these drugs when taken together. In addition, the safety and tolerability of the study drugs, when given together, will be evaluated. Information about any side effects that may occur will also be collected.
Fortrea Dallas, Tx is recruiting for:
-Healthy Males and Females of Non-Childbearing Potential, age 18-55
-Body Mass Index between 18-32
-Study involves 1 stay of 11 nights & 1 follow-up visit
-Compensation up to $5,671 may be provided for time and participation
-Refer a friend to receive $350 per qualified referral
Additional Details
G2:
Check-in: Oct 20
Check-out: Oct 31
Follow-up: Nov 5